Header Logo

Connection

Frederick Raal to Ultracentrifugation

Back to Details
This is a "connection" page, showing publications Frederick Raal has written about Ultracentrifugation.
Frederick Raal
Connection Strength
0,115
Ultracentrifugation
  1. Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials. J Am Coll Cardiol. 2014 Apr 08; 63(13):1278-1288.
    View in: PubMed
    Score: 0,115
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.